$MAIN Balance Sheet | Understand Stock

$MAIN

$54.07 +$0.73 (1.37%) Live

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022
ASSETS
Investments at fair value:
Control investments:
Affiliate investments:
Non‑Control/Non‑Affiliate investments:
Total investments at fair value:
Cash and cash equivalents
Interest and dividend receivable and other assets
Receivable for securities sold
Interest and dividend receivable
Prepaids and other assets
Deferred financing costs (net of accumulated amortization of $19,112 and $17,601, respectively)
Total assets
LIABILITIES and NET ASSETS
LIABILITIES
Credit Facilities
Line of Credit
Total credit Facilities

Accounts payable and other liabilities
Interest payable
Dividend payable
Deferred tax liability, net
Total liabilities
NET ASSETS
Common stock, $0.01 par value per share (150,000,000 shares authorized; 93,354,166 and 89,834,849 shares issued and outstanding, respectively)
Additional paid-in capital
Total undistributed earnings
Total net assets
Total liabilities and net assets
NET ASSET VALUE PER SHARE (in dollars per share)

Comments